Masimo Corporation
MASI
Clasificación en acciones
#2165
Masimo Corporation engages in the development, manufacture, and marketing of... Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, and methemoglobin. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Iris, iSirona, Replica, and UniView; and brain function monitoring, hemodynamic monitoring, regional oximetry, acoustic respiration rate monitoring, capnography and gas monitoring, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.
Precio por acción
$179.95
Última sincronización: 2026-06-12
Capitalización bursátil
$9.42B
Cambio (1 día)
0.00%
Cambio (1 año)
22.41%
País
US
Comercio Masimo Corporation (MASI)
Categoría
Healthcare
Ganancias de Masimo Corporation (MASI)
Ganancias en Apr 2026 TTM: $275.60M
Secondo gli ultimi rapporti finanziari di Masimo Corporation, gli utili attuali della società sono $275.60M. Nel 2023, la società ha registrato un utile di $88.10M, una disminución en comparación con agli utili del 2022, che erano di $193.40M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Masimo Corporation desde 2002 hasta 2026
Ganancias al final de cada año
| Año | Ganancias | Cambiar |
|---|---|---|
| 2026 (TTM) | $275.60M | -190.27% |
| 2024 | $-305.30M | -446.54% |
| 2023 | $88.10M | -54.45% |
| 2022 | $193.40M | -29.52% |
| 2021 | $274.40M | 4.06% |
| 2020 | $263.70M | 12.61% |
| 2019 | $234.17M | 9.54% |
| 2018 | $213.78M | 15.06% |
| 2017 | $185.80M | -57.14% |
| 2016 | $433.52M | 272.61% |
| 2015 | $116.35M | 14.02% |
| 2014 | $102.04M | 34.75% |
| 2013 | $75.73M | -9.66% |
| 2012 | $83.82M | -3.13% |
| 2011 | $86.53M | -19.56% |
| 2010 | $107.57M | 30.89% |
| 2009 | $82.18M | 13.52% |
| 2008 | $72.39M | 6.27% |
| 2007 | $68.12M | -78.33% |
| 2006 | $314.40M | 4,166.56% |
| 2005 | $7.37M | 0.00% |
| 2004 | 0.00 | -100.00% |
| 2003 | $-6.89M | 3,707.73% |
| 2002 | $-181.00K | 0.00% |
Ganancias de empresas similares o competidoras
| Empresa | Ganancias | Diferencia de ganancias | País |
|---|---|---|---|
| $7.51B | 2,625.33% |
US
|
|
| $5.56B | 1,918.51% |
IE
|
|
| $5.15B | 1,767.92% |
US
|
|
| $3.86B | 1,300.94% |
US
|
|
| - | - |
DE
|
